Novel Technologies for Rapid and Sensitive Biomonitoring in Humans (SBIR [R43/R44])

The summary for the Novel Technologies for Rapid and Sensitive Biomonitoring in Humans (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Novel Technologies for Rapid and Sensitive Biomonitoring in Humans (SBIR [R43/R44]): This Funding Opportunity Announcement (FOA) solicits Small Business Innovative Research (SBIR) grant applications from small business concerns (SBCs) to develop point-of-care or benchtop instruments, or other laboratory-based approaches for the characterization of major classes of analytes that include known and suspected toxicants and their major metabolites in human biological samples, including blood, urine, and saliva, which are likely to be available from both prospective and retrospective epidemiological cohorts. The focus of technology development is on the ability to detect multiple chemical analytes with high sensitivity and specificity in low volumes of biological specimens.